** SURMOUNT-1, 72-week study of adults with obesity using Mounjaro (tirzepatide 15mg)
The regulator said it conducted an independent assessment of the potential association between GLP-1 RAs and NAION, but found available evidence was conflicting and sought advice from the national advisory committee on medicines on whether the evidence required additional risk-mitigation measures
Little TJ, Pilichiewicz AN, Russo A, Phillips L, Jones KL, Nauck MA, Wishart J, Horowitz M, Feinle-Bisset C: Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses
Saxenda for weight management), and exenatide (Byetta, Bydureon)
Find Out if You Are Eligible If you want to see whether you are eligible to buy GLP-1 treatment through a regulated UK provider, the next step is to complete a short online consultation